EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France

Claire Tinévez, Philippe Lehours, Anne-Gaëlle Ranc, Yaniss Belaroussi, Fanny Velardo, Damien Dubois, Catherine Neuwirth, Hélène Pailhoriès, Marie Dorel, Genevieve Hery-Arnaud, Olivier Join-Lambert, Emmanuelle Gras und 19 weitere

Emerging Infectious Diseases · 2023

DOI: 10.3201/eid2903.221417 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von Claire Tinévez und 30 weiteren Autor:innen. Hauptthemen laut MEDLINE: Endocarditis, Campylobacter Infections, Bacteremia, Campylobacter. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of campylobacteriosis has substantially increased over the past decade, notably in France. Secondary localizations complicating invasive infections are poorly described. We aimed to describe vascular infection or endocarditis caused by Campylobacter spp. We included 57 patients from a nationwide 5-year retrospective study on Campylobacter spp. bacteremia conducted in France; 44 patients had vascular infections, 12 had endocarditis, and 1 had both conditions. Campylobacter fetus was the most frequently involved species (83%). Antibiotic treatment involved a β-lactam monotherapy (54%) or was combined with a fluoroquinolone or an aminoglycoside (44%). The mortality rate was 25%. Relapse occurred in 8% of cases and was associated with delayed initiation of an efficient antimicrobial therapy after the first symptoms, diabetes, and coexistence of an osteoarticular location. Cardiovascular Campylobacter spp. infections are associated with a high mortality rate. Systematically searching for those localizations in cases of C. fetus bacteremia may be warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocarditisCampylobacter InfectionsBacteremiaCampylobacterHumansRetrospective StudiesCampylobacter fetusAnti-Bacterial AgentsFranceMulticenter Studies as Topic

Stichwörter der Autor:innen

Campylobacter spp.Francebacteriabacterial infectionsgraft infectionsinfectious aortitisnon-HACEK endocarditisthrombophlebitis

Substanzen

Anti-Bacterial Agents

Zitieren

APA

Tinévez, C., Lehours, P., Ranc, A. G., Belaroussi, Y., Velardo, F., Dubois, D., Neuwirth, C., Pailhoriès, H., Dorel, M., Hery-Arnaud, G., Join-Lambert, O., Gras, E., Corvec, S., Codde, C., Fournier, D., Boijout, H., Doat, V., Bouard, L., Lagneaux, A. S., …, & Campylobacteremia Study Group (2023). Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France. Emerging Infectious Diseases. https://doi.org/10.3201/eid2903.221417

Vancouver

Tinévez C, Lehours P, Ranc AG, Belaroussi Y, Velardo F, Dubois D, et al. Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France. Emerging Infectious Diseases. 2023. doi:10.3201/eid2903.221417

BibTeX
@article{Tinvez2023,
  author = {Tinévez, Claire and Lehours, Philippe and Ranc, Anne-Gaëlle and Belaroussi, Yaniss and Velardo, Fanny and Dubois, Damien and Neuwirth, Catherine and Pailhoriès, Hélène and Dorel, Marie and Hery-Arnaud, Genevieve and Join-Lambert, Olivier and Gras, Emmanuelle and Corvec, Stéphane and Codde, Cyrielle and Fournier, Damien and Boijout, Hugo and Doat, Violaine and Bouard, Leslie and Lagneaux, Anne-Sophie and Pichon, Maxime and Couzigou, Célia and Letellier, Claire and Lemaignen, Adrien and Bille, Emmanuelle and Bérard, Xavier and Caradu, Caroline and Webster, Claire and Neau, Didier and Cazanave, Charles and Puges, Mathilde and Campylobacteremia Study Group, Campylobacteremia Study Group},
  title = {Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France},
  journal = {Emerging Infectious Diseases},
  year = {2023},
  doi = {10.3201/eid2903.221417}
}
Kostenlos starten →